Anna E Bortnick1, Traci M Bartz2, Joachim H Ix3, Michel Chonchol4, Alexander Reiner2, Mary Cushman5, David Owens2, Eddy Barasch6, David S Siscovick7, John S Gottdiener8, Jorge R Kizer1,9. 1. Cardiology Division, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA. 2. Department of Biostatistics, University of Washington, Seattle, Washington, USA. 3. Department of Medicine, and the Division of Preventive Medicine, Department of Family and Preventive Medicine, University of California, and Nephrology Section, Veteran Affairs San Diego Health Care System, San Diego, California, USA. 4. Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Aurora, Colorado, USA. 5. Departments of Pathology and Biochemistry, University of Vermont, Burlington, Vermont, USA. 6. Department of Research and Education, St. Francis Hospital, The Heart Center, Roslyn, New York, USA. 7. New York Academy of Medicine, New York, New York, USA. 8. Division of Cardiovascular Medicine, Department of Cardiology, University of Maryland, Baltimore, Maryland, USA. 9. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.
Abstract
OBJECTIVE: Calcification of the aortic valve and adjacent structures involves inflammatory, lipid and mineral metabolism pathways. We hypothesised that circulating biomarkers reflecting these pathways are associated with cardiac calcification in older adults. METHODS: We investigated the associations of various biomarkers with valvular and annular calcification in the Cardiovascular Health Study. Of the 5888 participants, up to 3585 were eligible after exclusions for missing biomarker, covariate or echocardiographic data. We evaluated analytes reflecting lipid (lipoprotein (Lp) (a), Lp-associated phospholipase A2 (LpPLA2) mass and activity), inflammatory (interleukin-6, soluble (s) CD14) and mineral metabolism (fetuin-A, fibroblast growth factor (FGF)-23) pathways that were measured within 5 years of echocardiography. The relationships of plasma biomarkers with aortic valve calcification (AVC), aortic annular calcification (AAC) and mitral annular calcification (MAC) were assessed with relative risk (RR) regression. RESULTS: Calcification was prevalent: AVC 59%, AAC 45% and MAC 41%. After adjustment, Lp(a), LpPLA2 mass and activity and sCD14 were positively associated with AVC. RRs for AVC per SD (95% CI) were as follows: Lp(a), 1.051 (1.022 to 1.081); LpPLA2 mass, 1.036 (1.006 to 1.066) and LpPLA2 activity, 1.037 (1.004 to 1.071); sCD14, 1.039 (1.005 to 1.073). FGF-23 was positively associated with MAC, 1.040 (1.004 to 1.078) and fetuin-A was negatively associated, 0.949 (0.911 to 0.989). No biomarkers were significantly associated with AAC. CONCLUSION: This study shows novel associations of circulating FGF-23 and fetuin-A with MAC, and LpPLA2 and sCD14 with AVC, confirming that previously reported for Lp(a). Further investigation of Lp and inflammatory pathways may provide added insight into the aetiology of AVC, while study of phosphate regulation may illuminate the pathogenesis of MAC. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
OBJECTIVE:Calcification of the aortic valve and adjacent structures involves inflammatory, lipid and mineral metabolism pathways. We hypothesised that circulating biomarkers reflecting these pathways are associated with cardiac calcification in older adults. METHODS: We investigated the associations of various biomarkers with valvular and annular calcification in the Cardiovascular Health Study. Of the 5888 participants, up to 3585 were eligible after exclusions for missing biomarker, covariate or echocardiographic data. We evaluated analytes reflecting lipid (lipoprotein (Lp) (a), Lp-associated phospholipase A2 (LpPLA2) mass and activity), inflammatory (interleukin-6, soluble (s) CD14) and mineral metabolism (fetuin-A, fibroblast growth factor (FGF)-23) pathways that were measured within 5 years of echocardiography. The relationships of plasma biomarkers with aortic valve calcification (AVC), aortic annular calcification (AAC) and mitral annular calcification (MAC) were assessed with relative risk (RR) regression. RESULTS:Calcification was prevalent: AVC 59%, AAC 45% and MAC 41%. After adjustment, Lp(a), LpPLA2 mass and activity and sCD14 were positively associated with AVC. RRs for AVC per SD (95% CI) were as follows: Lp(a), 1.051 (1.022 to 1.081); LpPLA2 mass, 1.036 (1.006 to 1.066) and LpPLA2 activity, 1.037 (1.004 to 1.071); sCD14, 1.039 (1.005 to 1.073). FGF-23 was positively associated with MAC, 1.040 (1.004 to 1.078) and fetuin-A was negatively associated, 0.949 (0.911 to 0.989). No biomarkers were significantly associated with AAC. CONCLUSION: This study shows novel associations of circulating FGF-23 and fetuin-A with MAC, and LpPLA2 and sCD14 with AVC, confirming that previously reported for Lp(a). Further investigation of Lp and inflammatory pathways may provide added insight into the aetiology of AVC, while study of phosphate regulation may illuminate the pathogenesis of MAC. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Parveen K Garg; Robyn L McClelland; Nancy S Jenny; Michael H Criqui; Philip Greenland; Robert S Rosenson; David S Siscovick; Neal Jorgensen; Mary Cushman Journal: Atherosclerosis Date: 2015-05-16 Impact factor: 5.162
Authors: Jason P Linefsky; Kevin D O'Brien; Ronit Katz; Ian H de Boer; Eddy Barasch; Nancy S Jenny; David S Siscovick; Bryan Kestenbaum Journal: J Am Coll Cardiol Date: 2011-07-12 Impact factor: 24.094
Authors: Caroline S Fox; Chao-Yu Guo; Martin G Larson; Ramachandran S Vasan; Helen Parise; Christopher J O'Donnell; Ralph B D'Agostino; John F Keaney; Emelia J Benjamin Journal: Am J Cardiol Date: 2006-03-29 Impact factor: 2.778
Authors: Gian M Novaro; Ronit Katz; Ronnier J Aviles; John S Gottdiener; Mary Cushman; Bruce M Psaty; Catherine M Otto; Brian P Griffin Journal: J Am Coll Cardiol Date: 2007-10-29 Impact factor: 24.094
Authors: David M Tehrani; Julius M Gardin; David Yanez; Calvin H Hirsch; Donald M Lloyd-Jones; Phyllis K Stein; Nathan D Wong Journal: Atherosclerosis Date: 2013-09-05 Impact factor: 5.162
Authors: Nancy Swords Jenny; Cam Solomon; Mary Cushman; Russell P Tracy; Jeanenne J Nelson; Bruce M Psaty; Curt D Furberg Journal: Atherosclerosis Date: 2009-09-20 Impact factor: 5.162
Authors: Angelica Ezeigwe; Oluwaseun E Fashanu; Di Zhao; Matthew J Budoff; James D Otvos; Isac C Thomas; Samia Mora; Martin Tibuakuu; Erin D Michos Journal: Atherosclerosis Date: 2019-01-24 Impact factor: 5.162
Authors: Michael Lichtenauer; Bernhard Wernly; Vera Paar; Ilonka Rohm; Christian Jung; Atilla Yilmaz; Uta C Hoppe; Paul Christian Schulze; Daniel Kretzschmar; Rudin Pistulli Journal: J Clin Lab Anal Date: 2017-02-18 Impact factor: 2.352
Authors: Luiz Rafael P Cavalcanti; Michel Pompeu B O Sá; Álvaro M Perazzo; Antonio C Escorel Neto; Rafael A F Gomes; Alexander Weymann; Konstantin Zhigalov; Arjang Ruhparwar; Ricardo C Lima Journal: Curr Atheroscler Rep Date: 2020-02-07 Impact factor: 5.113
Authors: Anna E Bortnick; Shuo Xu; Ryung S Kim; Bryan Kestenbaum; Joachim H Ix; Nancy S Jenny; Ian H de Boer; Erin D Michos; George Thanassoulis; David S Siscovick; Matthew J Budoff; Jorge R Kizer Journal: Atherosclerosis Date: 2019-04-13 Impact factor: 5.162
Authors: Martin Tibuakuu; Di Zhao; Ian H de Boer; Eliseo Guallar; Anna E Bortnick; Pamela L Lutsey; Matthew J Budoff; Jorge R Kizer; Bryan R Kestenbaum; Erin D Michos Journal: Am J Cardiol Date: 2017-05-11 Impact factor: 2.778
Authors: Anna E Bortnick; Petra Buzkova; James D Otvos; Majken K Jensen; Michael Y Tsai; Matthew J Budoff; Rachel H Mackey; Samar R El Khoudary; Elda Favari; Ryung S Kim; Carlos J Rodriguez; George Thanassoulis; Jorge R Kizer Journal: Arterioscler Thromb Vasc Biol Date: 2022-08-18 Impact factor: 10.514
Authors: Daniele Massera; Shuo Xu; Traci M Bartz; Anna E Bortnick; Joachim H Ix; Michel Chonchol; David S Owens; Eddy Barasch; Julius M Gardin; John S Gottdiener; John R Robbins; David S Siscovick; Jorge R Kizer Journal: Arch Osteoporos Date: 2017-05-30 Impact factor: 2.617
Authors: Jihyeon Lim; Jennifer T Aguilan; Rani S Sellers; Fnu Nagajyothi; Louis M Weiss; Ruth Hogue Angeletti; Anna E Bortnick Journal: J Mol Histol Date: 2020-08-13 Impact factor: 2.611
Authors: Daniele Massera; Maria G Trivieri; Jack P M Andrews; Samantha Sartori; Ronan Abgral; Andrew R Chapman; William S A Jenkins; Alex T Vesey; Mhairi K Doris; Tania A Pawade; Kang H Zheng; Jorge R Kizer; David E Newby; Marc R Dweck Journal: Circ Cardiovasc Imaging Date: 2019-02 Impact factor: 7.792